These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22781134)

  • 1. Improving antivenom availability and accessibility: science, technology, and beyond.
    Gutiérrez JM
    Toxicon; 2012 Sep; 60(4):676-87. PubMed ID: 22781134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Snakebite envenoming from a global perspective: Towards an integrated approach.
    Gutiérrez JM; Williams D; Fan HW; Warrell DA
    Toxicon; 2010 Dec; 56(7):1223-35. PubMed ID: 19951718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Needs and availability of snake antivenoms: relevance and application of international guidelines.
    Scheske L; Ruitenberg J; Bissumbhar B
    Int J Health Policy Manag; 2015 Apr; 4(7):447-57. PubMed ID: 26188809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ending the drought: new strategies for improving the flow of affordable, effective antivenoms in Asia and Africa.
    Williams DJ; Gutiérrez JM; Calvete JJ; Wüster W; Ratanabanangkoon K; Paiva O; Brown NI; Casewell NR; Harrison RA; Rowley PD; O'Shea M; Jensen SD; Winkel KD; Warrell DA
    J Proteomics; 2011 Aug; 74(9):1735-67. PubMed ID: 21640209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.
    Gutiérrez JM; Burnouf T; Harrison RA; Calvete JJ; Kuch U; Warrell DA; Williams DJ;
    Bull World Health Organ; 2014 Jul; 92(7):526-32. PubMed ID: 25110378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. History and perspectives on how to ensure antivenom accessibility in the most remote areas in Brazil.
    Fan HW; Monteiro WM
    Toxicon; 2018 Sep; 151():15-23. PubMed ID: 29908262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of neglect: analysis of the sub-Saharan African snake antivenom market and the global context.
    Brown NI
    PLoS Negl Trop Dis; 2012; 6(6):e1670. PubMed ID: 22679521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for the production, control and regulation of snake antivenom immunoglobulins].
    Chippaux JP
    Biol Aujourdhui; 2010; 204(1):87-91. PubMed ID: 20950580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing the impact of snakebite envenoming in Latin America and the Caribbean: achievements and challenges ahead.
    Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):530-7. PubMed ID: 25096295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antivenoms for snakebite envenomings.
    Gutiérrez JM; León G; Lomonte B; Angulo Y
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop.
    Gutiérrez JM; Fan HW; Silvera CL; Angulo Y
    Toxicon; 2009 May; 53(6):625-30. PubMed ID: 19673076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global Availability of Antivenoms: The Relevance of Public Manufacturing Laboratories.
    Gutiérrez JM
    Toxins (Basel); 2018 Dec; 11(1):. PubMed ID: 30586868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omics meets biology: application to the design and preclinical assessment of antivenoms.
    Calvete JJ; Sanz L; Pla D; Lomonte B; Gutiérrez JM
    Toxins (Basel); 2014 Dec; 6(12):3388-405. PubMed ID: 25517863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and first experiences of the National Serum Depot in the Netherlands.
    Dijkman MA; van der Zwan CW; de Vries I
    Toxicon; 2012 Sep; 60(4):700-5. PubMed ID: 22538194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assessment of the availability and use of antivenom in the district of Bamako, Mali, West Africa].
    Dramé BS; Dabo M; Diani N; Cissé B
    Bull Soc Pathol Exot; 2012 Aug; 105(3):179-83. PubMed ID: 22707256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bringing antivenoms to Sub-Saharan Africa.
    Stock RP; Massougbodji A; Alagón A; Chippaux JP
    Nat Biotechnol; 2007 Feb; 25(2):173-7. PubMed ID: 17287747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antivenoms for the treatment of snakebite envenomings: the road ahead.
    Gutiérrez JM; León G; Burnouf T
    Biologicals; 2011 May; 39(3):129-42. PubMed ID: 21429763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Situation of snakebite, antivenom market and access to antivenoms in ASEAN countries.
    Patikorn C; Ismail AK; Abidin SAZ; Blanco FB; Blessmann J; Choumlivong K; Comandante JD; Doan UV; Mohamed Ismail Z; Khine YY; Maharani T; Nwe MT; Qamruddin RM; Safferi RS; Santamaria E; Tiglao PJG; Trakulsrichai S; Vasaruchapong T; Chaiyakunapruk N; Taychakhoonavudh S; Othman I
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35296460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antivenom: the most cost-effective treatment in the world?
    Brown N; Landon J
    Toxicon; 2010 Jun; 55(7):1405-7. PubMed ID: 20171241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antivenom preclinical efficacy testing against Asian snakes and their availability in Asia: A systematic review.
    Soopairin S; Patikorn C; Taychakhoonavudh S
    PLoS One; 2023; 18(7):e0288723. PubMed ID: 37467278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.